Results 21 to 30 of about 69,156 (235)

Biomarkers of host response predict primary end-point radiological pneumonia in Tanzanian children with clinical pneumonia : a prospective cohort study [PDF]

open access: yes, 2015
Diagnosing pediatric pneumonia is challenging in low-resource settings. The World Health Organization (WHO) has defined primary end-point radiological pneumonia for use in epidemiological and vaccine studies.
Nimerta Rajwans   +65 more
core   +1 more source

The impact of tracheotomy on levels of procalcitonin in patients without sepsis: a prospective study

open access: yesClinics, 2015
OBJECTIVE: Procalcitonin is a reliable biomarker of infection and sepsis. We aimed to determine whether tracheotomy influences the procalcitonin concentrations in patients without sepsis and assess whether operative duration and procedure affect the peak
Xingui Dai   +6 more
doaj   +1 more source

Hospital physicians’ experiences with procalcitonin – implications for antimicrobial stewardship; a qualitative study

open access: yesBMC Infectious Diseases, 2020
Background Procalcitonin is an inflammatory biomarker that is sensitive for bacterial infections and a promising clinical decision aid in antimicrobial stewardship programs.
Ingrid Christensen   +4 more
doaj   +1 more source

Rituximab-induced Procalcitonin Elevation [PDF]

open access: yes, 2020
Procalcitonin has been studied as a marker of bacterial lung infection. It frequently guides clinical practice and antibiotic management. However, procalcitonin is known to have false positive results in certain scenarios.
Uduman, Junior, Bauer, Zachery
core   +1 more source

Procalcitonin in Pediatrics

open access: yes, 2013
Over the past two decades, the body of literature on the clinical usefulness of procalcitonin (PCT) in adults has grown rapidly. Although this approach has led to increased insight, it has also prompted debate regarding its potential use in diagnosis and management of severe infection.
1   +6 more
openaire   +5 more sources

Procalcitonin as biomarker of antibiotic effectivity in communityacquired pneumonia [PDF]

open access: yes, 2015
Major therapy for community-acquired pneumonia (CAP) is antibiotics. Procalcitonin used as the measure of antibioticseffectiveness. Procalcitonin is specific biomarker that elevates in acute bacterial infection.
Samirah, -   +3 more
core   +1 more source

Usefulness of sialic acid for diagnosis of sepsis in critically ill patients: a retrospective study

open access: yesBMC Anesthesiology, 2020
Background Early diagnosis of sepsis is very important. It is necessary to find effective and adequate biomarkers in order to diagnose sepsis. In this study, we compared the value of sialic acid and procalcitonin for diagnosing sepsis.
Bo Yao   +4 more
doaj   +1 more source

Diagnostic Accuracy of Procalcitonin upon Emergency Department Admission during SARS-CoV-2 Pandemic

open access: yesAntibiotics, 2022
Introduction: Procalcitonin is a marker for bacterial diseases and has been used to guide antibiotic prescription. Procalcitonin accuracy, measured at admission, in patients with community-acquired pneumonia (CAP), is unknown in the current severe acute ...
Stefano Malinverni   +10 more
doaj   +1 more source

Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings.

open access: yesPLoS ONE, 2012
UnlabelledProcalcitonin has been shown to be useful in separating infection from non-infective disorders. However, infection is often paralleled by tissue inflammation.
Fiona J McCann   +5 more
doaj   +1 more source

The Usefulness of Procalcitonin in the Diagnosis of Appendicitis in Children: A Pilot Study

open access: yesEmergency Medicine International, 2012
Objective. To assess the predictive value of procalcitonin in detecting acute appendicitis (AP) in children, and to determine a cutoff value of procalcitonin which can safely include/exclude the diagnosis of acute appendicitis in children with acute ...
Abu N. G. A. Khan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy